Australian biotech market today 18.03.09
Wednesday, 18 March, 2009
Pharma and biotech stocks were down slightly at 2.30pm today, on an up-and-down day for the All Ords.
Alchemia (ASX:ACL) is up yet again on the market today, trading at 32c and still basking in the washout from its partner filing a new drug application for generic fondaparinux.
Avexa (ASX:AVX) is down a touch from its recent gains, Biota (ASX:BTA) is up 5c to 61c and Cytopia (ASX:CYT) is up a cent.
Cochlear (ASX:COH) keeps rising and is now trading over $50 while CSL (ASX:CSL) is down a bit.
Newly listed Genera Biosystems (ASX:GBI) is active, up 2c, as is Halcygen (ASX:HGN).
Mesoblast (ASX:MSB) is down 2c, while Nanosonics (ASX:NAN) is up.
Universal Biosensors (ASX:UBI) is up 5c.
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
